beta-amyloid 38 (Aβ38) antibody and antigen (Recombinant protein)

Diagnostic beta-amyloid 38 (Aβ38) antibodies (anti-beta-amyloid 38, anti-Aβ38) and antigens (recombinant beta-amyloid 38 (Aβ38) protein) for Neurodegenerative diseases Aβ38 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Neurodegenerative diseases diagnostics products collection >>


Product information

Catalog No. Description US $ Price (per mg)
GMP-h-Aβ38-Ag01 Beta-amyloid 38 (Aβ38) antigen $3090.00
GMP-h-Aβ38-Ab01 Anti-human Aβ38 mouse monoclonal antibody (mAb) $1953.00
GMP-h-Aβ38-Ab02 Anti-human Aβ38 mouse monoclonal antibody (mAb) $1953.00
GMP-h-Aβ38-Ab03 Anti-human Aβ38 human monoclonal antibody (mAb) $1953.00
GMP-h-Aβ38-Ab04 Anti-human Aβ38 human monoclonal antibody (mAb) $1953.00

Size: 1mg | 10mg | 100mg



Product Description

Cat No. of Pruducts GMP-h-Aβ38-Ag01
Product Name Beta-amyloid 38 (Aβ38) antigen
Target/Biomarker beta-amyloid 38 (Aβ38)
Alias of Target/Biomarker AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP
Expression platform synthesized
Isotypes NA
Bioactivity validation beta-amyloid 38 (Aβ38) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in Aβ38 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation
Products description Beta-amyloid 38 (Aβ38) antigen is synthesized
Purity Purity: ≥95% (HPLC)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Pruducts GMP-h-Aβ38-Ab01,GMP-h-Aβ38-Ab02
Product Name Anti-human Aβ38 mouse monoclonal antibody (mAb)
Target/Biomarker beta-amyloid 38 (Aβ38)
Alias of Target/Biomarker AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation Human beta-amyloid 38 (Aβ38) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 38 (Aβ38) antibodies in Aβ38 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation.
Tag mFc
Products description Anti-human Aβ38 mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 38 (Aβ38) antibodies.
Reconized/Reactive Species Human
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No. of Pruducts GMP-h-Aβ38-Ab03,GMP-h-Aβ38-Ab04
Product Name Anti-human Aβ38 human monoclonal antibody (mAb)
Target/Biomarker beta-amyloid 38 (Aβ38)
Alias of Target/Biomarker AAA, ABETA, ABPP, AD1I, CTFgamma, CVAP, PN-II, PN2, alpha-sAPP, preA4, APP
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation Human beta-amyloid 38 (Aβ38) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other beta-amyloid 38 (Aβ38) antibodies in Aβ38 level test of Neurodegenerative diseases (Alzheimer Disease(AD)) and related syndrome evaluation.
Tag hFc
Products description Anti-human Aβ38 mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
Reconized/Reactive Species Human
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.
Formulation Supplied as a 0.2 μM filtered solution of PBS,PH7.4.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    Higher CSF Aβ38 levels are associated with lower risk of AD-related changes in 2 independent clinical cohorts. Meta-analysis of 17 studies did not show a convincing difference between Alzheimer’s disease patients and controls: the effect size was quite small (0.921) and the p value was only marginally significant (0.03).



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment